This article is more than 5 years old. Information may no longer be current.

Presenting VA not indicative of outcome in patients with CRVO

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Visual and anatomic outcomes cannot usually be predicted with presenting visual acuity for younger patients with central retinal vein occlusion, according to a study.

Franco Recchia, MD, and colleagues at Associated Retinal Consultants in Royal Oak, Mich., retrospectively compared the records of 67 patients with central retinal vein occlusion (CRVO) who were 55 years of age or younger.

The median presenting VA was 20/50. At least one systemic disease was present in 67% of the patients. Visual decline was most common within 3 to 6 months after CRVO onset. After 12 months, visual recovery was unlikely.

Of 22 patients who initially presented with 20/40 or better, 36% declined to 20/400 or worse at the most recent follow-up. Of the 10 patients with a presenting VA of 20/200 to 20/400, eight improved to 20/60 or better by last follow-up.

The study is published in the March issue of Archives of Ophthalmology.